Cedric Hermans/ institutroialbertdeux.be;
Jan Blatný/praguemorning.cz
Apr 1, 2026, 11:46
Cedric Hermans: Revisiting the Role of Factor VIII in Haemophilia A in 2026 on E-Learning Insights
Cedric Hermans, Head of Haemophilia Centre at the Saint-Luc University Hospital, Brussels, shared a post on LinkedIn:
“Revisiting the role of FVIII in Haemophilia A in 2026
In this episode, Cedric Hermans sits down with Jan Blatný, Consultant Haematologist at Masaryk University and University Hospital Brno, EHCC and EuroBloodNet Centre, and former EAHAD President (2024–2026), to explore the evolving role of Factor VIII in the management of haemophilia A in 2026.
As new therapies such as emicizumab, rebalancing agents, and gene therapy reshape the treatment landscape, this conversation revisits where FVIII remains essential.”
Stay updated with Hemostasis Today.
-
Jun 10, 2026, 16:48Maha Othman: How Artificial Intelligence and Machine Learning Can Improve Risk Assessment of Cancer-Associated Thrombosis
-
Jun 10, 2026, 15:41Maxime Dely: Did You Know That A Single Platelet Donation Can Help Two Patients?
-
Jun 10, 2026, 15:37Wolfgang Miesbach: Why B-Cell Depletion Is Not Always Enough in Immune Thrombocytopenia
-
Jun 10, 2026, 15:30Shadi Tabibian: Living With Unexplained Bleeding – Insights From the Vienna Bleeding Biobank
-
Jun 10, 2026, 15:27Siddharth Mittal: Transfusion Medicine as the Gateway to Cell and Gene Therapy
-
Jun 10, 2026, 15:23Jonathan Douxfils: New Data on Hemostasis, VTE, and Breast Cancer to Rethink the Reference Standard
-
Jun 10, 2026, 15:16Rena Hirani: The Role of Paper Substrates and Storage Conditions
-
Jun 10, 2026, 15:06Ashkan Golshani: Congratulations to Our Team on Recent Publications in Molecular Biology and AI-Driven Research
-
Jun 10, 2026, 14:52David Ferreira: Standardizing Thrombin Generation Testing in Portugal and Spain